Skip to main content

Advertisement

SpringerLink
Log in

Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers

  • Letter to the Editor
  • Published:
Virchows Archiv Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Muller-Myhsok B, Neveling K, Kiechle M, Mathew CG, Schindler D, Schmutzler RK, Hanenberg H (2010) Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 42(5):410–414. doi:10.1038/ng.569

    Article  CAS  PubMed  Google Scholar 

  2. Palacios J, Honrado E, Osorio A, Cazorla A, Sarrio D, Barroso A, Rodriguez S, Cigudosa JC, Diez O, Alonso C, Lerma E, Sanchez L, Rivas C, Benitez J (2003) Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. Clin Cancer Res 9(10 Pt 1):3606–3614

    CAS  PubMed  Google Scholar 

  3. Pelttari LM, Heikkinen T, Thompson D, Kallioniemi A, Schleutker J, Holli K, Blomqvist C, Aittomaki K, Butzow R, Nevanlinna H (2011) RAD51C is a susceptibility gene for ovarian cancer. Hum Mol Genet 20(16):3278–3288. doi:10.1093/hmg/ddr229

    Article  CAS  PubMed  Google Scholar 

  4. Cunningham JM, Cicek MS, Larson NB, Davila J, Wang C, Larson MC, Song H, Dicks EM, Harrington P, Wick M, Winterhoff BJ, Hamidi H, Konecny GE, Chien J, Bibikova M, Fan JB, Kalli KR, Lindor NM, Fridley BL, Pharoah PP, Goode EL (2014) Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status. Sci Rep 4:4026. doi:10.1038/srep04026

    Article  CAS  PubMed  Google Scholar 

  5. Ozretic L, Rhiem K, Huss S, Wappenschmidt B, Markiefka B, Sinn P, Schmutzler RK, Buettner R (2011) High nuclear poly(adenosine diphosphate-ribose) polymerase expression is predictive for BRCA1- and BRCA2-deficient breast cancer. J Clin Oncol 29(34):4586–4588. doi:10.1200/JCO.2011.38.1988, author reply 4588

    Article  PubMed  Google Scholar 

  6. Schnurbein G, Hauke J, Wappenschmidt B, Weber-Lassalle N, Engert S, Hellebrand H, Garbes L, Becker A, Neidhardt G, Rhiem K, Meindl A, Schmutzler RK, Hahnen E (2013) RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families. Breast Cancer Res 15(6):R120. doi:10.1186/bcr3589

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Susanne Steiner and Michaela Giedigkeit from the Institute of Pathology, University Hospital Bonn, for their excellent technical support and the centers Hannover, Leipzig, Dresden, and Duesseldorf of the German consortium for hereditary breast and ovarian cancer (GC-HBOC) for providing samples. This study was kindly supported by the German Cancer Aid (grant number 109076).

Conflict of interest

R.K. Schmutzler and A. Meindl may benefit financially from a license agreement on RAD51C between the University of Cologne and Myriad.

Author information

Authors and Affiliations

  1. Institute of Pathology, University Hospital Bonn, Sigmund-Freud-Strasse 25, 53127, Bonn, Germany

    Heidrun Gevensleben

  2. Molecular Oncology, Department of Obstetrics Gynecology, University Hospital of Cologne, Cologne, Germany

    Verena Bossung, Barbara Wappenschmidt & Rita Katharina Schmutzler

  3. Department of Obstetrics and Gynecology, University Hospital of Luebeck, Luebeck, Germany

    Verena Bossung

  4. Department of Obstetrics and Gynecology, Division of Tumor Genetics, Klinikum rechts der Isar der Technischen Universitaet Muenchen, Munich, Germany

    Alfons Meindl

  5. Department of Obstetrics and Gynecology, University Hospital Ulm, Ulm, Germany

    Nikolaus de Gregorio

  6. Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid, Spain

    Ana Osorio

  7. Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain

    Atocha Romero

  8. Institute of Pathology, University Hospital of Cologne, Cologne, Germany

    Reinhard Buettner & Birgid Markiefka

Authors
  1. Heidrun Gevensleben
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Verena Bossung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alfons Meindl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Barbara Wappenschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nikolaus de Gregorio
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ana Osorio
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Atocha Romero
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Reinhard Buettner
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Birgid Markiefka
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Rita Katharina Schmutzler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heidrun Gevensleben.

Additional information

Heidrun Gevensleben and Verena Bossung contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 96 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gevensleben, H., Bossung, V., Meindl, A. et al. Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers. Virchows Arch 465, 365–369 (2014). https://doi.org/10.1007/s00428-014-1619-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-014-1619-1

Keywords

Search

Navigation